Amgen Inc. Contracts & Agreements

478 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Amgen Inc.'s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Amgen Inc.
Biotechnology
NY
2025
Amgen Inc. Non-Qualified Stock Option Grant Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2025
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2025
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2025
Amgen Inc. Non-Qualified Stock Option Grant Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. 2009 Performance Award Program (As Amended and Restated Through May 31, 2024)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. 2009 Director Equity Incentive Program (Amended and Restated as of May 31, 2024)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. Restricted Stock Unit Agreement (Director Equity Incentive Program)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. Cash-Settled Restricted Stock Unit Agreement (Director Equity Incentive Program)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2024
Description of Amgen Inc.’s Common Stock and 2.000% Senior Notes Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Amgen Inc.
Biotechnology
NY
2024
Amgen Inc. Non-Qualified Stock Option Grant Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2024
Amgen Inc. 2009 Director Equity Incentive Program (Amended and Restated Effective January 1, 2024)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2024
Fifth Amendment to Amgen Inc. Supplemental Retirement Plan (Horizon Therapeutics Integration)
Retirement Agreements
Amgen Inc.
Biotechnology
2024
Fourth Amendment to Amgen Nonqualified Deferred Compensation Plan (Effective January 1, 2024)
Retirement Agreements
Amgen Inc.
Biotechnology
2024
Employment Agreement between Amgen Inc. and Dr. James E. Bradner (Executive Vice President, R&D & Chief Scientific Officer)
Employment Agreements
Amgen Inc.
Biotechnology
2024
Second Amendment to Collaboration Agreement between Amgen Inc. and BeiGene
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2023
Third Amended and Restated Credit Agreement among Amgen Inc., Borrowing Subsidiaries, and Lender Banks (March 9, 2023)
Credit Agreements
Amgen Inc.
Biotechnology
DE
2023
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (March 2023)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2023
Amgen Inc. Underwriting Agreement for $24.25 Billion Senior Notes Offering (2025–2063)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2023
Description of Amgen Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2023
Amgen Inc. Non-Qualified Stock Option Grant Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2023
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2023
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2023
Fourth Amendment to Amgen Inc. Supplemental Retirement Plan (as Amended and Restated Effective October 16, 2013)
Retirement Agreements
Amgen Inc.
Biotechnology
2023
Amendment No. 3 to Share Purchase Agreement between BeiGene, Ltd. and Amgen Inc.
Purchase Agreements
Amgen Inc.
Biotechnology
2023
Term Loan Credit Agreement among Amgen Inc., Citibank, N.A., Bank of America, N.A., Goldman Sachs Bank USA, and Mizuho Bank, Ltd. dated December 22, 2022
Credit Agreements
Amgen Inc.
Biotechnology
DE
2022
Transaction Agreement among Amgen Inc., Pillartree Limited, and Horizon Therapeutics plc (December 11, 2022)
Merger Agreements
Amgen Inc.
Biotechnology
DE
2022
Appendix 3: Conditions of Acquisition and Scheme between Amgen Parties and the Company
Merger Agreements
Amgen Inc.
Biotechnology
2022
Bridge Credit Agreement among Amgen Inc., Citibank, N.A., Bank of America, N.A., and Other Lenders (December 12, 2022)
Credit Agreements
Amgen Inc.
Biotechnology
DE
2022
First Amendment to Sourcing and Supply Agreement Between Amgen USA Inc. and DaVita Inc.
Supply Agreements
Amgen Inc.
Biotechnology
2022
Amgen Inc. Underwriting Agreement for $3 Billion Senior Notes Offering (2029, 2033, 2053)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2022
Amgen Inc. Officer’s Certificate Relating to Issuance of Senior Notes Due 2029, 2033, and 2053
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2022
First Amendment to Collaboration Agreement between Amgen Inc. and BeiGene
Collaboration Agreements
Amgen Inc.
Biotechnology
2022
Agreement and Plan of Merger among ChemoCentryx, Inc., Amgen Inc., and Carnation Merger Sub, Inc. dated August 3, 2022
Merger Agreements
Amgen Inc.
Biotechnology
DE
2022
Amgen Inc. Executive Incentive Plan (as Amended and Restated Effective January 1, 2022)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2022
Form of Accelerated Share Repurchase (ASR) Agreement between Amgen Inc. and Dealer
Repurchase Agreements
Amgen Inc.
Biotechnology
NY
2022
Amgen Inc. Underwriting Agreement for $4 Billion Senior Notes Offering (2029–2062)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2022
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2029, 2032, 2052, 2062) under Indenture with The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2022
Description of Amgen Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2022
Amgen Inc. Form of Grant of Stock Option Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2022
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2022
Amgen Inc. Performance Unit Award Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2022
Third Amendment to Amgen Inc. Supplemental Retirement Plan (Effective October 20, 2021)
Retirement Agreements
Amgen Inc.
Biotechnology
2022
Third Amendment to Amgen Nonqualified Deferred Compensation Plan (Effective January 1, 2022)
Compensation Agreements
Amgen Inc.
Biotechnology
2022
Aircraft Time Sharing Agreement between Amgen Inc. and Robert A. Bradway
Services Agreements
Amgen Inc.
Biotechnology
NY
2022
Amendment No. 8 to the Collaboration Agreement between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2022
Amendment No. 3 to Exclusive License and Collaboration Agreement between Novartis Pharma AG and Amgen Inc.
License Agreements
Amgen Inc.
Biotechnology
2022
Agreement and Plan of Merger among Amgen Inc., Tuxedo Merger Sub, Inc., Teneobio, Inc., and Fortis Advisors LLC (July 27, 2021)
Merger Agreements
Amgen Inc.
Biotechnology
DE
2021
Amgen Inc. Underwriting Agreement for $5 Billion Senior Notes Offering (2028–2052) with Citigroup, Morgan Stanley, Barclays, and Goldman Sachs
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2021
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes Due 2028, 2032, 2041, and 2052
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2021
Amended and Restated Collaboration Agreement between Amgen Inc. and Novartis Pharma AG (June 2, 2021)
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2021
Agreement and Plan of Merger among Amgen Inc., Franklin Acquisition Sub, Inc., and Five Prime Therapeutics, Inc. dated March 4, 2021
Merger Agreements
Amgen Inc.
Biotechnology
DE
2021
Description of Amgen Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Amgen Inc.
Biotechnology
NY
2021
Amgen Inc. Non-Qualified Stock Option Grant Agreement
Stock Agreements
Amgen Inc.
Biotechnology
DE
2021
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2021
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2021
Amgen Inc. 2009 Director Equity Incentive Program (Amended and Restated Effective January 1, 2021)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2021
Amendment No. 7 to Collaboration Agreement between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2021
Amendment No. 2 to Collaboration Agreement between Novartis Pharma AG and Amgen Inc.
Collaboration Agreements
Amgen Inc.
Biotechnology
2020
Restated Amendment No. 2 to Share Purchase Agreement between BeiGene, Ltd. and Amgen Inc.
Purchase Agreements
Amgen Inc.
Biotechnology
NY
2020
Officer’s Certificate of Amgen Inc. Relating to 2.770% Senior Notes Due 2053
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2020
Registration Rights Agreement among Amgen Inc. and Dealer Managers (August 17, 2020)
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2020
Amendment No. 2 to Collaboration Agreement and Release between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2020
Amgen Inc. Underwriting Agreement for $4 Billion Senior Notes Offering (2027, 2031, 2040, 2050)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2020
Amgen Inc. Officer’s Certificate for 2.300% Senior Notes Due 2031
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2020
Amgen Inc. Executive Employment Offer Letter to Peter Griffith (October 18, 2019)
Employment Agreements
Amgen Inc.
Biotechnology
2020
Side Letter to Collaboration Agreement and Stivarga Agreement between Onyx Pharmaceuticals, Inc. and Bayer HealthCare LLC (February 13, 2020)
Collaboration Agreements
Amgen Inc.
Biotechnology
2020
Amendment No. 2 to Share Purchase Agreement between BeiGene, Ltd. and Amgen Inc.
Purchase Agreements
Amgen Inc.
Biotechnology
NY
2020
Amgen Inc. $5 Billion Senior Notes Underwriting Agreement with Citigroup, Goldman Sachs, Barclays, and Morgan Stanley (2020)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2020
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2025–2050)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2020
Description of Amgen Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Amgen Inc.
Biotechnology
NY
2020
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2020
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2020
Amgen Inc. 2009 Director Equity Incentive Program (Amended and Restated as of December 11, 2019)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2020
Amgen Inc. Director Restricted Stock Unit Agreement under 2009 Equity Incentive Program
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2020
Amgen Inc. Cash-Settled Restricted Stock Unit Agreement for Directors under 2009 Director Equity Incentive Program
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2020
Second Amendment to Amgen Inc. Supplemental Retirement Plan (Celgene Service Credit)
Retirement Agreements
Amgen Inc.
Biotechnology
2020
Second Amendment to the Amgen Nonqualified Deferred Compensation Plan (2013, as Amended)
Retirement Agreements
Amgen Inc.
Biotechnology
2020
Guarantee Agreement between BeiGene, Ltd. and Amgen Inc. (October 31, 2019)
Guaranty Agreements
Amgen Inc.
Biotechnology
2020
Letter Agreement Regarding Treatment of Product Inventory between Amgen Inc. and Celgene Corporation
Purchase Agreements
Amgen Inc.
Biotechnology
2020
Collaboration Agreement between Amgen Inc., BeiGene Switzerland GmbH, and BeiGene, Ltd. (October 31, 2019)
Collaboration Agreements
Amgen Inc.
Biotechnology
CA
2020
Second Amended and Restated Credit Agreement among Amgen Inc., Borrowing Subsidiaries, and Lender Banks (2019)
Credit Agreements
Amgen Inc.
Biotechnology
DE
2019
Asset Purchase Agreement between Celgene Corporation and Amgen Inc. dated August 25, 2019
Purchase Agreements
Amgen Inc.
Biotechnology
NY
2019
Letter Agreement Regarding Romosozumab Launch Cost Allocation Between Amgen Inc. and UCB Celltech (June 25, 2019)
Collaboration Agreements
Amgen Inc.
Biotechnology
2019
Amgen Inc. Global Non-Qualified Stock Option Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2019
Amgen Inc. Global Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2019
Amgen Inc. Global Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2019
Employment Offer Agreement Between Amgen Inc. and Murdo Gordon Dated July 25, 2018
Employment Agreements
Amgen Inc.
Biotechnology
2018
Amendment No. 1 to Credit Agreement among Amgen Inc., Citibank, N.A., and Lenders (March 9, 2018)
Credit Agreements
Amgen Inc.
Biotechnology
VA
2018
Amendment No. 1 to Collaboration Agreement between Novartis Pharma AG and Amgen Inc.
Collaboration Agreements
Amgen Inc.
Biotechnology
2018
Amgen Inc. Global Non-Qualified Stock Option Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2018
Amgen Inc. Restricted Stock Unit Agreement (Director Equity Incentive Program)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2018
Amgen Inc. 2009 Performance Award Program (as Amended Through December 12, 2017)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2018
Amgen Inc. Global Performance Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2018
Amgen Inc. 2009 Director Equity Incentive Program (Amended and Restated October 24, 2017)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2018
Amgen Inc. Restricted Stock Unit Agreement for Director Program under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2018
Amgen Inc. Cash-Settled Restricted Stock Unit Agreement for Director Equity Incentive Program
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2018
Amgen Inc. $1,000,000,000 3.200% Senior Notes Due 2027 Underwriting Agreement with J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and BNP Paribas Securities Corp.
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2017
Officer’s Certificate of Amgen Inc. Relating to 3.200% Senior Notes Due 2027
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2017
Exclusive License and Collaboration Agreement between Amgen Inc. and Novartis Pharma AG (August 28, 2015)
License Agreements
Amgen Inc.
Biotechnology
CA
2017
Amendment No. 1 to Exclusive License and Collaboration Agreement between Novartis Pharma AG and Amgen Inc.
License Agreements
Amgen Inc.
Biotechnology
2017
Amendment No. 2 to Exclusive License and Collaboration Agreement between Novartis Pharma AG and Amgen Inc.
License Agreements
Amgen Inc.
Biotechnology
2017
Collaboration Agreement between Amgen Inc. and Novartis Pharma AG (April 21, 2017)
Collaboration Agreements
Amgen Inc.
Biotechnology
CA
2017
Amgen Inc. Officer’s Certificate for Issuance of Senior Notes (2019, 2020, 2022) under Indenture
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2017
Second Amendment to Amgen Inc. Executive Incentive Plan (Effective January 1, 2017)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2017
Amgen Inc. Form of Stock Option Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
2017
Amgen Inc. Form of Global Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2017
Amgen Inc. Performance Unit Award Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2017
Amgen Inc. Employment Offer Letter to Lori A. Johnston for SVP Human Resources Position
Employment Agreements
Amgen Inc.
Biotechnology
2017
Amendment No. 2 to Collaboration and License Agreement between Amgen Inc. and UCB Celltech
Collaboration Agreements
Amgen Inc.
Biotechnology
2017
First Amendment to the Amgen Inc. Supplemental Retirement Plan (Effective October 14, 2016)
Retirement Agreements
Amgen Inc.
Biotechnology
2016
First Amendment to the Amgen Nonqualified Deferred Compensation Plan (Effective October 14, 2016)
Retirement Agreements
Amgen Inc.
Biotechnology
2016
Officer’s Certificate Relating to Issuance of Amgen Inc. Senior Notes (2021, 2023, 2026)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2016
Officer’s Certificate of Amgen Inc. Relating to Issuance of 4.563% Senior Notes Due 2048 and 4.663% Senior Notes Due 2051
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2016
Second Amendment to Amgen Inc. Amended and Restated 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2016
Amgen Inc. 2009 Equity Incentive Plan Non-Qualified Stock Option Agreement (Form)
Stock Agreements
Amgen Inc.
Biotechnology
2016
Amgen Inc. Form of Global Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2016
Amgen Inc. 2009 Performance Award Program (as Amended Through March 2, 2016)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2016
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2016
Amgen Inc. CHF 700,000,000 0.410% Bonds Due 2023 Permanent Global Certificate
Note Agreements
Amgen Inc.
Biotechnology
CA
2016
Officer’s Certificate of Amgen Inc. Relating to Issuance of 1.250% Senior Notes Due 2022 and 2.000% Senior Notes Due 2026
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2016
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2015
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2015
Amgen Inc. Form of Global Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2015
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2015
Side Letter to Collaboration Agreement between Onyx Pharmaceuticals, Inc. and Bayer HealthCare LLC (May 29, 2015)
Collaboration Agreements
Amgen Inc.
Biotechnology
2015
First Amendment to Amgen Inc. Amended and Restated 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2015
Amgen Inc. Form of Global Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2015
Amgen Inc. Performance Unit Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2015
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2015
Amgen Inc. Performance Unit Award Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2015
Amendment No. 1 to Collaboration Agreement between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2015
Amended and Restated Credit Agreement among Amgen Inc., Borrowing Subsidiaries, and Lender Banks (July 30, 2014)
Credit Agreements
Amgen Inc.
Biotechnology
DE
2014
Amgen Inc. Indenture Agreement with The Bank of New York Mellon Trust Company, N.A. (May 22, 2014)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2014
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2014)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2014
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2014
Amgen Inc. 2009 Equity Incentive Plan Performance Unit Agreement (Form)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2014
Amendment No. 14 to the Shareholders’ Agreement of Kirin-Amgen, Inc. (Kirin Holdings, Kyowa Hakko Kirin, Amgen, Kirin-Amgen)
Shareholders Agreements
Amgen Inc.
Biotechnology
CA
2014
Amgen Inc. 2009 Performance Award Program (as Amended Through December 13, 2013)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2014
Amgen Inc. Supplemental Retirement Plan (As Amended and Restated Effective October 16, 2013)
Retirement Agreements
Amgen Inc.
Biotechnology
RI
2014
Amgen Nonqualified Deferred Compensation Plan (As Amended and Restated Effective October 16, 2013)
Compensation Agreements
Amgen Inc.
Biotechnology
CA
2014
Amgen Inc. Agreement and General Release of Claims with Executive Employee
Separation Agreements
Amgen Inc.
Biotechnology
2014
Amendment No. 5 to Integrated Facilities Management Services Agreement between Jones Lang LaSalle Americas, Inc. and Amgen Inc.
Services Agreements
Amgen Inc.
Biotechnology
2013
Term Loan Facility Credit Agreement among Amgen Inc. and Bank of America, N.A. et al. (September 20, 2013)
Credit Agreements
Amgen Inc.
Biotechnology
DE
2013
Agreement and Plan of Merger among Amgen Inc., Arena Acquisition Company, and Onyx Pharmaceuticals, Inc. (August 24, 2013)
Merger Agreements
Amgen Inc.
Biotechnology
2013
Commitment Letter for Acquisition Financing between Amgen Inc. and Bank of America, JPMorgan, and Barclays
Amgen Inc.
Biotechnology
NY
2013
Amgen Inc. 2009 Equity Incentive Plan Stock Option Award Notice and Agreement
Stock Agreements
Amgen Inc.
Biotechnology
2013
Amgen Inc. Restricted Stock Unit Award Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2013
Amgen Inc. 2009 Amended Performance Award Program (as of March 6, 2013)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2013
Amgen Inc. Performance Unit Award Notice and Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2013
Amgen Inc. 2009 Amended and Restated Director Equity Incentive Program (Effective January 1, 2013)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2013
Amgen Inc. Restricted Stock Unit Agreement for Director Equity Incentive Program
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2013
Consulting Services Agreement between Amgen Inc. and Fabrizio Bonanni (2013)
Consulting Agreements
Amgen Inc.
Biotechnology
CA
2013
Amendment No. 4 to Integrated Facilities Management Services Agreement between Jones Lang LaSalle Americas, Inc. and Amgen Inc.
Services Agreements
Amgen Inc.
Biotechnology
2013
Amgen Inc. 2009 Performance Award Program (As Amended December 13, 2012)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2013
Amgen Inc. 2009 Amended and Restated Director Equity Incentive Program (Effective January 1, 2013)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2013
Amgen Inc. Restricted Stock Unit Agreement for Director Equity Incentive Program
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2013
First Amendment to Amgen Inc. Executive Incentive Plan (Amended and Restated Effective January 1, 2009)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2013
Amendment No. 1 to License Agreement between Amgen Inc. and Takeda Pharmaceutical Company Limited
License Agreements
Amgen Inc.
Biotechnology
CA
2013
Amendment No. 2 to License Agreement between Amgen Inc. and Takeda Pharmaceutical Company Limited
License Agreements
Amgen Inc.
Biotechnology
CA
2013
Amgen Inc. Stock Option Award Notice and Grant Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
2012
Amgen Inc. Restricted Stock Unit Award Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2012
Fifth Amendment to the Amgen Inc. Supplemental Retirement Plan (Effective August 27, 2012)
Retirement Agreements
Amgen Inc.
Biotechnology
2012
Fourth Amendment to the Amgen Nonqualified Deferred Compensation Plan (Effective August 27, 2012)
Retirement Agreements
Amgen Inc.
Biotechnology
2012
Officers' Certificate of Amgen Inc. Relating to 2.125% Senior Notes Due 2019 and 4.000% Senior Notes Due 2029
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2012
Fourth Amendment to the Amgen Inc. Supplemental Retirement Plan (Effective June 18, 2012)
Retirement Agreements
Amgen Inc.
Biotechnology
2012
Third Amendment to the Amgen Nonqualified Deferred Compensation Plan (as Amended and Restated Effective January 1, 2009)
Compensation Agreements
Amgen Inc.
Biotechnology
2012
Amgen Inc. Restricted Stock Unit Agreement for Kevin W. Sharer under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2012
Amgen Inc. Performance Unit Agreement with Kevin W. Sharer under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2012
Officers' Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2017, 2022, 2043)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2012
Amgen Inc. Grant of Stock Option Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
2012
Share Purchase Agreement among MN Sellers, S1hhat Sellers, Amgen Ilaç Tic. Ltd. Şti, and Amgen Worldwide Holdings B.V. regarding Mustafa Nevzat İlaç Sanayii Anonim Şirketi
Purchase Agreements
Amgen Inc.
Biotechnology
2012
Second Amendment to the Amgen Inc. Supplemental Retirement Plan (Effective October 12, 2011)
Retirement Agreements
Amgen Inc.
Biotechnology
2012
Third Amendment to the Amgen Inc. Supplemental Retirement Plan (Effective January 1, 2012)
Retirement Agreements
Amgen Inc.
Biotechnology
2012
Second Amendment to the Amgen Nonqualified Deferred Compensation Plan (Effective October 12, 2011)
Compensation Agreements
Amgen Inc.
Biotechnology
2012
Agreement and Plan of Merger among Micromet, Inc., Amgen Inc., and Armstrong Acquisition Corp.
Merger Agreements
Amgen Inc.
Biotechnology
2012
Credit Agreement among Amgen Inc., Borrowing Subsidiaries, and Various Banks, dated December 2, 2011
Credit Agreements
Amgen Inc.
Biotechnology
DE
2011
Officers' Certificate of Amgen Inc. Relating to Issuance of 4.375% Senior Notes Due 2018 and 5.50% Senior Notes Due 2026
Amgen Inc.
Biotechnology
NY
2011
Officers' Certificate Relating to Amgen Inc. Senior Notes Issuance (2014, 2016, 2021, 2041)
Amgen Inc.
Biotechnology
NY
2011
Amendment No. 7 to Master Services Agreement between Amgen Inc. and International Business Machines Corporation
Services Agreements
Amgen Inc.
Biotechnology
2011
Amendment No. 3 to Integrated Facilities Management Services Agreement between Jones Lang LaSalle Americas, Inc. and Amgen Inc.
Modification Agreements
Amgen Inc.
Biotechnology
2011
First Amendment to the Amgen Supplemental Retirement Plan (Effective April 11, 2011)
Retirement Agreements
Amgen Inc.
Biotechnology
2011
Integrated Facilities Management Services Agreement between Amgen Inc. and Jones Lang LaSalle Americas, Inc.
Services Agreements
Amgen Inc.
Biotechnology
CA
2011
Officers' Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2016, 2021, 2042)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2011
Agreement and Plan of Merger among BioVex Group, Inc., BioVex Limited, Amgen Inc., Andromeda Acquisition Corp., and Forbion 1 Management B.V.
Merger Agreements
Amgen Inc.
Biotechnology
DE
2011
First Amendment to Agreement and Plan of Merger among BioVex Group, Amgen Inc., and Others
Merger Agreements
Amgen Inc.
Biotechnology
2011
Amgen Inc. 2009 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2011
Amgen Inc. Change of Control Severance Plan (as Amended and Restated)
Change of Control Agreements
Amgen Inc.
Biotechnology
2011
Amgen Inc. Amended and Restated Change of Control Severance Plan (Effective December 9, 2010)
Change of Control Agreements
Amgen Inc.
Biotechnology
2010
Amendment No. 6 to Master Services Agreement between Amgen Inc. and International Business Machines Corporation
Services Agreements
Amgen Inc.
Biotechnology
2010
Officers' Certificate of Amgen Inc. Relating to 3.45% Senior Notes Due 2020 and 4.95% Senior Notes Due 2041
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2010
First Amendment to Amgen Inc. Executive Nonqualified Retirement Plan (Effective July 21, 2010)
Retirement Agreements
Amgen Inc.
Biotechnology
2010
Amgen Inc. Stock Option and Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2010
Officers' Certificate of Amgen Inc. Relating to Issuance of 4.50% Senior Notes Due 2020 and 5.75% Senior Notes Due 2040
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2010
Amgen Inc. Form of Stock Option Agreement and Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2010
Amendment No. 5 to Master Services Agreement between Amgen Inc. and International Business Machines Corporation
Services Agreements
Amgen Inc.
Biotechnology
2010
Amgen Inc. 2009 Equity Incentive Plan Non-Qualified Stock Option Agreement
Stock Agreements
Amgen Inc.
Biotechnology
DE
2009
Collaboration Agreement between Amgen Inc. and Glaxo Group Limited (GlaxoSmithKline) for Commercialization of Ivory
Collaboration Agreements
Amgen Inc.
Biotechnology
DE
2009
Expansion Agreement between Amgen Inc. and Glaxo Group Limited (GlaxoSmithKline) – Ivory Product
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2009
Amendment No. 1 to Credit Agreement between Amgen Inc. and Participating Banks, Dated May 18, 2009
Credit Agreements
Amgen Inc.
Biotechnology
NY
2009
Amendment No. 7 to Enbrel Supply Agreement among Immunex, Wyeth, and Boehringer Ingelheim Pharma
Supply Agreements
Amgen Inc.
Biotechnology
2009
Amgen Inc. Restricted Stock Unit Agreement under 2009 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2009
Amgen Inc. 2009 Equity Incentive Plan Non-Qualified Stock Option Agreement
Stock Agreements
Amgen Inc.
Biotechnology
2009
Amgen Inc. Non-Qualified Stock Option Agreement for Directors under 2009 Equity Incentive Program
Stock Agreements
Amgen Inc.
Biotechnology
2009
Amgen Inc. Restricted Stock Unit Agreement (Director Equity Incentive Program)
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2009
Amendment and Restatement of the Amgen Change of Control Severance Plan (Effective December 9, 2008)
Change of Control Agreements
Amgen Inc.
Biotechnology
2009
Master Services Agreement between Amgen Inc. and International Business Machines Corporation (IBM)
Services Agreements
Amgen Inc.
Biotechnology
CA
2009
Integrated Facilities Management Services Agreement between Amgen Inc. and Jones Lang LaSalle Americas, Inc.
Services Agreements
Amgen Inc.
Biotechnology
CA
2009
Officers' Certificate of Amgen Inc. Relating to Issuance of 5.70% Senior Notes Due 2019 and 6.40% Senior Notes Due 2039
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2009
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
2008
Amgen Inc. Stock Option Grant Agreement for Employees
Stock Agreements
Amgen Inc.
Biotechnology
DE
2008
Amgen Inc. Supplemental Retirement Plan (As Amended and Restated Effective January 1, 2009)
Retirement Agreements
Amgen Inc.
Biotechnology
RI
2008
Amgen Inc. Executive Nonqualified Retirement Plan (Amended and Restated as of January 1, 2009)
Retirement Agreements
Amgen Inc.
Biotechnology
CA
2008
Amendment No. 2 to Amendment No. 6 to the Enbrel Supply Agreement among Immunex, Wyeth, and Boehringer Ingelheim Pharma
Supply Agreements
Amgen Inc.
Biotechnology
2008
Amendment No. 1 to Amendment No. 2 to the Enbrel Supply Agreement among Immunex, Wyeth, and Boehringer Ingelheim Pharma
Supply Agreements
Amgen Inc.
Biotechnology
2008
Amgen Inc. Underwriting Agreement for $1 Billion Senior Notes (Goldman Sachs & Merrill Lynch, May 20, 2008)
Underwriting Agreements
Amgen Inc.
Biotechnology
CA
2008
Officers' Certificate of Amgen Inc. Relating to Issuance of 6.15% Senior Notes Due 2018 and 6.90% Senior Notes Due 2038
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2008
Fifth Amendment to the Amgen Inc. Supplemental Retirement Plan
Retirement Agreements
Amgen Inc.
Biotechnology
2008
Multi-Product License Agreement Between Amgen Inc. and Takeda Pharmaceutical Company Limited (Japan)
License Agreements
Amgen Inc.
Biotechnology
CA
2008
License Agreement for Motesanib Diphosphate Between Amgen Inc. and Takeda Pharmaceutical Company Limited (February 1, 2008)
License Agreements
Amgen Inc.
Biotechnology
CA
2008
Supply Agreement between Amgen Inc. and Takeda Pharmaceutical Company Limited dated February 1, 2008
Supply Agreements
Amgen Inc.
Biotechnology
CA
2008
Sale and Purchase Agreement between Amgen Inc. and Takeda Pharmaceutical Company Limited (February 1, 2008)
Purchase Agreements
Amgen Inc.
Biotechnology
DE
2008
Agreement of Resignation, Appointment and Acceptance among Amgen Inc., The Bank of New York, and Citibank, N.A. (February 15, 2008)
Indenture Agreements
Amgen Inc.
Biotechnology
2008
Amgen Inc. Employee Non-Qualified Stock Option Grant Agreement under 1991 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2008
Second Amendment to Amgen Inc. Amended and Restated Employee Stock Purchase Plan
Stock Agreements
Amgen Inc.
Biotechnology
2008
Fifth Amendment to the Amgen Nonqualified Deferred Compensation Plan
Retirement Agreements
Amgen Inc.
Biotechnology
2008
Amendment No. 6 to Enbrel Supply Agreement among Immunex, Wyeth, and Boehringer Ingelheim Pharma
Supply Agreements
Amgen Inc.
Biotechnology
2008
Amended and Restated Amgen Inc. Performance Award Program (Effective December 10, 2007)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2007
Fourth Amendment to the Amgen Inc. Supplemental Retirement Plan (Effective October 1, 2007)
Retirement Agreements
Amgen Inc.
Biotechnology
2007
First Amendment to the Amgen Inc. Executive Nonqualified Retirement Plan
Retirement Agreements
Amgen Inc.
Biotechnology
2007
Fourth Amendment to the Amgen Nonqualified Deferred Compensation Plan (Effective October 1, 2007)
Compensation Agreements
Amgen Inc.
Biotechnology
2007
Collaboration Agreement between Amgen Inc. and Daiichi Sankyo Company, Limited (July 11, 2007)
Collaboration Agreements
Amgen Inc.
Biotechnology
DE
2007
Credit Agreement between Amgen Inc., Citicorp USA, Inc., Barclays Bank PLC, and Other Financial Institutions (November 2, 2007)
Credit Agreements
Amgen Inc.
Biotechnology
NY
2007
Amendment No. 13 to the Shareholders' Agreement of Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
CA
2007
Purchase Agreement for $4 Billion Senior Notes between Amgen Inc. and Initial Purchasers (Morgan Stanley, Merrill Lynch, et al.) dated May 24, 2007
Purchase Agreements
Amgen Inc.
Biotechnology
CA
2007
Purchase Agreement between Amgen Inc. and Merrill Lynch International dated May 29, 2007
Purchase Agreements
Amgen Inc.
Biotechnology
DE
2007
Officers' Certificate of Amgen Inc. Relating to Issuance of Senior Notes (May 30, 2007)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2007
Third Amendment to the Amgen Inc. Supplemental Retirement Plan
Retirement Agreements
Amgen Inc.
Biotechnology
2007
Eighth Amendment to Amgen Inc. Change of Control Severance Plan
Change of Control Agreements
Amgen Inc.
Biotechnology
2007
Third Amendment to the Amgen Nonqualified Deferred Compensation Plan
Retirement Agreements
Amgen Inc.
Biotechnology
2007
Fourth Amendment to the Amgen Retirement and Savings Plan
Retirement Agreements
Amgen Inc.
Biotechnology
2006
Seventh Amendment to the Amgen Inc. Change of Control Severance Plan
Change of Control Agreements
Amgen Inc.
Biotechnology
2006
Agreement and Plan of Merger among Amgen Inc., Aviator Merger Sub, Inc., Avidia, Inc., and Alloy Ventures, Inc.
Merger Agreements
Amgen Inc.
Biotechnology
DE
2006
Third Amendment to the Amgen Retirement and Savings Plan (Merger of Amgen Fremont Plan)
Retirement Agreements
Amgen Inc.
Biotechnology
2006
Amgen Inc. and JPMorgan Chase Bank, N.A. Indenture for $2.5 Billion 0.125% Convertible Senior Notes Due 2011
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2006
Amgen Inc. $2,500,000,000 0.375% Convertible Senior Notes Due 2013 Indenture with JPMorgan Chase Bank, N.A.
Indenture Agreements
Amgen Inc.
Biotechnology
DE
2006
Second Amendment to the Amgen Retirement and Savings Plan (Effective January 1, 2006)
Retirement Agreements
Amgen Inc.
Biotechnology
2006
First Amendment to the Amgen Retirement and Savings Plan (as Amended and Restated Effective January 1, 2006)
Retirement Agreements
Amgen Inc.
Biotechnology
2006
Second Amendment to the Amgen Supplemental Retirement Plan (Effective July 1, 2006)
Retirement Agreements
Amgen Inc.
Biotechnology
2006
Sixth Amendment to the Amgen Inc. Change in Control Severance Plan
Change of Control Agreements
Amgen Inc.
Biotechnology
2006
Restricted Stock Purchase Agreement between Amgen Inc. and Dennis Fenton
Stock Agreements
Amgen Inc.
Biotechnology
2006
Confirmation of OTC Convertible Note Hedge Agreement between Amgen Inc. and Merrill Lynch International
Amgen Inc.
Biotechnology
NY
2006
Confirmation of OTC Convertible Note Hedge between Amgen Inc. and Merrill Lynch International
Amgen Inc.
Biotechnology
NY
2006
Confirmation of OTC Convertible Note Hedge between Amgen Inc. and Morgan Stanley & Co. International Limited
Amgen Inc.
Biotechnology
NY
2006
Purchase Agreement between Amgen Inc. and Citigroup Global Markets Inc. for Common Stock Repurchase
Purchase Agreements
Amgen Inc.
Biotechnology
NY
2006
Amgen Inc. and JPMorgan Chase Bank, N.A. Indenture for 0.125% Convertible Senior Notes Due 2011
Indenture Agreements
Amgen Inc.
Biotechnology
DE
2006
Indenture Agreement for 0.375% Convertible Senior Notes due 2013 between Amgen Inc. and JPMorgan Chase Bank, N.A.
Indenture Agreements
Amgen Inc.
Biotechnology
DE
2006
Amgen Inc. Purchase Agreement for $5 Billion Convertible Senior Notes with Initial Purchasers
Purchase Agreements
Amgen Inc.
Biotechnology
CA
2006
Agreement and Plan of Merger among Abgenix, Inc., Amgen Inc., and Athletics Merger Sub, Inc. dated December 14, 2005
Merger Agreements
Amgen Inc.
Biotechnology
DE
2005
Amended and Restated Amgen Inc. 1991 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
2005
Amended and Restated Amgen Inc. 1999 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
WA
2005
First Amendment to Credit Agreement between Amgen Inc. and Citibank N.A. (December 6, 2005)
Credit Agreements
Amgen Inc.
Biotechnology
NY
2005
Second Amendment to Amgen Nonqualified Deferred Compensation Plan (2005)
Compensation Agreements
Amgen Inc.
Biotechnology
2005
Amendment No. 5 to Enbrel Supply Agreement among Immunex, Wyeth, and Boehringer Ingelheim Pharma
Supply Agreements
Amgen Inc.
Biotechnology
2005
Amendment and Restatement of Amgen Retirement and Savings Plan (Effective January 1, 2006)
Retirement Agreements
Amgen Inc.
Biotechnology
CA
2005
First Amendment to Amgen Nonqualified Deferred Compensation Plan (2005)
Compensation Agreements
Amgen Inc.
Biotechnology
2005
First Amendment to the Amgen Supplemental Retirement Plan (Effective January 1, 2005)
Retirement Agreements
Amgen Inc.
Biotechnology
2005
Amgen Inc. Amended and Restated Employee Stock Option Grant Agreement
Stock Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. Amended and Restated Employee Stock Option Grant Agreement
Stock Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. Amended and Restated Employee Stock Option Grant Agreement
Stock Agreements
Amgen Inc.
Biotechnology
2005
Amendment No. 12 to Shareholders’ Agreement of Kirin-Amgen Among Kirin Brewery Co., Ltd., Amgen Inc., and Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
2005
Amendment No. 4 to Enbrel Supply Agreement among Immunex, Wyeth, and Boehringer Ingelheim Pharma
Supply Agreements
Amgen Inc.
Biotechnology
2005
First Amendment to Amgen Inc. Amended and Restated Employee Stock Purchase Plan (July 12, 2005)
Equity Distribution Agreements
Amgen Inc.
Biotechnology
2005
Amendment No. 3 to Amended and Restated Promotion Agreement among Wyeth, Amgen Inc., and Immunex Corporation
Collaboration Agreements
Amgen Inc.
Biotechnology
2005
Amgen Inc. Amended and Restated 1999 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
WA
2005
Amgen Inc. Employee Stock Option Grant Agreement under 1997 Equity Incentive Plan
Stock Agreements
Amgen Inc.
Biotechnology
DE
2005
First Amendment to the Amgen Retirement and Savings Plan (2003)
Retirement Agreements
Amgen Inc.
Biotechnology
2005
Second Amendment to the Amgen Retirement and Savings Plan (Effective June 1, 2004)
Retirement Agreements
Amgen Inc.
Biotechnology
2005
Third Amendment to Amgen Inc. Change of Control Severance Plan
Change of Control Agreements
Amgen Inc.
Biotechnology
2005
Fourth Amendment to Amgen Inc. Change of Control Severance Plan
Change of Control Agreements
Amgen Inc.
Biotechnology
2005
First Supplemental Indenture to Indenture for Amgen Inc. Liquid Yield Option Notes due 2032 (Zero Coupon – Senior) between Amgen Inc. and LaSalle Bank National Association,...
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2005
Fourth Amendment to the Amgen Retirement and Savings Plan (Including Merger of Amgen Salary Savings Plan)
Retirement Agreements
Amgen Inc.
Biotechnology
2004
Fifth Amendment to the Amgen Inc. Change of Control Severance Plan
Change of Control Agreements
Amgen Inc.
Biotechnology
2004
Amgen Inc. Performance Unit Agreement under 1991 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2004
Amgen Inc. Officers' Certificate Relating to 4.00% Senior Notes Due 2009 and 4.85% Senior Notes Due 2014
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2004
Amgen Inc. $2 Billion Senior Notes Purchase Agreement with Initial Purchasers (2004)
Purchase Agreements
Amgen Inc.
Biotechnology
CA
2004
Amgen Inc. Incentive Stock Option Grant Agreement under 1991 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
2004
Third Amendment to Amgen Retirement and Savings Plan (Effective January 1, 2003, as Amended)
Retirement Agreements
Amgen Inc.
Biotechnology
2004
Amgen Inc. Supplemental Retirement Plan (As Amended and Restated Effective January 1, 2005)
Retirement Agreements
Amgen Inc.
Biotechnology
RI
2004
Amgen Nonqualified Deferred Compensation Plan (As Amended and Restated Effective January 1, 2005)
Compensation Agreements
Amgen Inc.
Biotechnology
DE
2004
Credit Agreement dated July 16, 2004 among Amgen Inc., Citicorp USA, Inc., Barclays Bank PLC, and Other Financial Institutions
Credit Agreements
Amgen Inc.
Biotechnology
NY
2004
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2004
Agreement and Plan of Merger among Amgen Inc., Arrow Acquisition, LLC, and Tularik Inc. dated March 28, 2004
Merger Agreements
Amgen Inc.
Biotechnology
DE
2004
Stockholder Voting Agreement between Amgen Inc. and Tularik Inc. Stockholders dated March 28, 2004
Voting Agreements
Amgen Inc.
Biotechnology
DE
2004
Amgen Retirement and Savings Plan (Amended and Restated as of January 1, 2003)
Retirement Agreements
Amgen Inc.
Biotechnology
CA
2004
First Amendment to the Amgen Nonqualified Deferred Compensation Plan (Effective January 1, 2002)
Compensation Agreements
Amgen Inc.
Biotechnology
2004
Amendment No. 1 to Enbrel Supply Agreement between Genentech Inc. and Immunex Corporation
Supply Agreements
Amgen Inc.
Biotechnology
2004
Amendment No. 3 to Enbrel Supply Agreement between Genentech, Inc. and Immunex Corporation
Supply Agreements
Amgen Inc.
Biotechnology
2004
Amendment No. 4 to Enbrel Supply Agreement between Genentech Inc. and Immunex Corporation
Supply Agreements
Amgen Inc.
Biotechnology
2004
Amgen Inc. Board Resolutions Amending 1991 Equity Incentive Plan and Approving Director Equity Incentive Program
Compensation Agreements
Amgen Inc.
Biotechnology
DE
2004
Amgen Inc. Restricted Stock Unit Agreement for Directors under Equity Incentive Program
Equity Distribution Agreements
Amgen Inc.
Biotechnology
DE
2004
Restricted Stock Purchase Agreement between Amgen Inc. and Brian M. McNamee
Stock Agreements
Amgen Inc.
Biotechnology
2003
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
2003
Amendment No. 3 to Enbrel Supply Agreement among Immunex, Wyeth, and Boehringer Ingelheim Pharma
Supply Agreements
Amgen Inc.
Biotechnology
2003
Amgen Limited 2000 UK Company Employee Share Option Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
2003
Amgen Inc. and Beth C. Seidenberg Restricted Stock Purchase Agreement (January 14, 2002)
Stock Agreements
Amgen Inc.
Biotechnology
2003
Amendment No. 2 to Enbrel Supply Agreement among Immunex, Wyeth, and Boehringer Ingelheim Pharma KG
Supply Agreements
Amgen Inc.
Biotechnology
2002
Asset Purchase Agreement between Immunex Corporation and Schering Aktiengesellschaft dated May 2, 2002
Purchase Agreements
Amgen Inc.
Biotechnology
WA
2002
Amendment No. 1 to Asset Purchase Agreement between Immunex Corporation and Schering Aktiengesellschaft
Purchase Agreements
Amgen Inc.
Biotechnology
2002
Amendment No. 2 to Asset Purchase Agreement between Immunex Corporation and Schering Aktiengesellschaft
Purchase Agreements
Amgen Inc.
Biotechnology
2002
Restricted Stock Purchase Agreement between Amgen Inc. and Edward V. Fritzky
Stock Agreements
Amgen Inc.
Biotechnology
2002
Restricted Stock Purchase Agreement between Amgen Inc. and Joseph P. Miletich
Stock Agreements
Amgen Inc.
Biotechnology
2002
Second Amendment to the Amgen Supplemental Retirement Plan (Effective January 1, 2002)
Retirement Agreements
Amgen Inc.
Biotechnology
2002
Third Amendment to the Amgen Retirement and Savings Plan (as Amended and Restated Effective October 23, 2000)
Retirement Agreements
Amgen Inc.
Biotechnology
2002
Amgen Inc. Executive Nonqualified Retirement Plan Agreement
Retirement Agreements
Amgen Inc.
Biotechnology
CA
2002
Amgen Nonqualified Deferred Compensation Plan Effective January 1, 2002
Compensation Agreements
Amgen Inc.
Biotechnology
CA
2002
Amended and Restated Promotion Agreement between Immunex Corporation, American Home Products Corporation, and Amgen Inc. for Enbrel Promotion
Collaboration Agreements
Amgen Inc.
Biotechnology
NJ
2002
Agreement Regarding Governance and Commercial Matters among American Home Products, American Cyanamid, and Amgen (December 16, 2001)
Cooperation Agreements
Amgen Inc.
Biotechnology
DE
2002
Agreement and Plan of Merger among Amgen Inc., AMS Acquisition Inc., and Immunex Corporation (December 16, 2001)
Merger Agreements
Amgen Inc.
Biotechnology
WA
2001
Shareholder Voting Agreement among Amgen Inc., American Home Products Corporation, MDP Holdings, Inc., and Lederle Parenterals, Inc. dated December 16, 2001
Voting Agreements
Amgen Inc.
Biotechnology
DE
2001
Second Amendment to Amgen Inc. Change of Control Severance Plan
Change of Control Agreements
Amgen Inc.
Biotechnology
2001
Restricted Stock Purchase Agreement between Amgen Inc. and Richard Nanula
Stock Agreements
Amgen Inc.
Biotechnology
2001
Restricted Stock Purchase Agreement between Amgen Inc. and Roger M. Perlmutter
Stock Agreements
Amgen Inc.
Biotechnology
2001
Shareholders' Agreement of Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
CA
2001
Amendment Nos. 4 and 5 to Shareholders' Agreement of Kirin-Amgen, Inc. among Kirin Brewery Co., Ltd., Amgen, and Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
CA
2001
Assignment and License Agreement between Amgen and Kirin-Amgen, Inc. (July 1, 1986)
License Agreements
Amgen Inc.
Biotechnology
CA
2001
G-CSF European License Agreement between Kirin-Amgen, Inc. and Amgen, Inc. (December 30, 1986)
License Agreements
Amgen Inc.
Biotechnology
CA
2001
G-CSF United States License Agreement between Kirin-Amgen, Inc. and Amgen Inc.
License Agreements
Amgen Inc.
Biotechnology
CA
2001
Amendment No. 1 to G-CSF United States License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 2 to G-CSF United States License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 10 to Shareholders' Agreement of Kirin-Amgen Among Kirin Brewery Co., Ltd., Amgen Inc., and Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 11 to Shareholders' Agreement of Kirin-Amgen Among Kirin Brewery Co., Ltd., Amgen Inc., and Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
CA
2001
Amendment No. 1 to G-CSF European License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 2 to G-CSF European License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 3 to G-CSF European License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 4 to G-CSF European License Agreement between Amgen Inc. and Kirin-Amgen, Inc.
License Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 6 to Shareholders' Agreement of Kirin-Amgen, Inc. (Kirin Brewery Co., Ltd., Amgen Inc., and Kirin-Amgen, Inc.)
Shareholders Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 7 to Shareholders' Agreement of Kirin-Amgen, Inc. (Kirin Brewery Co., Ltd., Amgen Inc., and Kirin-Amgen, Inc.)
Shareholders Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 8 to Shareholders' Agreement of Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
DE
2001
Amendment No. 9 to Shareholders' Agreement of Kirin-Amgen among Kirin Brewery Co., Ltd., Amgen Inc., and Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
2001
Amendment No. 1 to Shareholders' Agreement of Kirin-Amgen, Inc.
Shareholders Agreements
Amgen Inc.
Biotechnology
CA
2000
Product License Agreement between Amgen and Ortho Pharmaceutical Corporation
License Agreements
Amgen Inc.
Biotechnology
CA
2000
Product License Agreement between Kirin-Amgen, Inc. and Ortho Pharmaceutical Corporation (Erythropoietin)
License Agreements
Amgen Inc.
Biotechnology
CA
2000
Amgen Inc. Amended and Restated Employee Stock Purchase Plan
Stock Agreements
Amgen Inc.
Biotechnology
2000
First Amendment to Amgen Inc. Change of Control Severance Plan
Change of Control Agreements
Amgen Inc.
Biotechnology
2000
Amendment No. 2 to Asset Purchase Agreement between Amgen Inc. and Celgene Corporation
Modification Agreements
Amgen Inc.
Biotechnology
2020
Amgen Inc. Grant of Non-Qualified Stock Option Agreement with Employee
Warrant Agreements
Amgen Inc.
Biotechnology
DE
2020
Amendment No. 1 to Asset Purchase Agreement between Celgene Corporation and Amgen Inc.
Modification Agreements
Amgen Inc.
Biotechnology
2019
Irrevocable Guarantee Agreement between Bristol-Myers Squibb Company and Amgen Inc. (August 25, 2019)
Guaranty Agreements
Amgen Inc.
Biotechnology
DE
2019
Amgen Inc. Underwriting Agreement for $3.5 Billion Senior Notes Offering (2017)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2017
Amgen Inc. Underwriting Agreement for $3.75 Billion Senior Notes Offering (2021, 2023, 2026, 2045)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2016
Registration Rights Agreement among Amgen Inc. and Dealer Managers (June 14, 2016)
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2016
Terms and Conditions of CHF 700,000,000 0.410% Bonds Due 2023 Issued by the Issuer
Note Agreements
Amgen Inc.
Biotechnology
NY
2016
Amgen Inc. €2,000,000,000 Senior Notes Underwriting Agreement with Merrill Lynch International, Barclays Bank PLC, J.P. Morgan Securities plc, and Deutsche Bank AG, London Branch
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2016
Employment Offer Letter Between Amgen Inc. and Jonathan P. Graham Dated April 29, 2015
Employment Agreements
Amgen Inc.
Biotechnology
2015
Amgen Inc. Underwriting Agreement for $3.5 Billion Senior Notes Offering (2020, 2022, 2025, 2045)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2015
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2020, 2022, 2025, 2045)
Note Agreements
Amgen Inc.
Biotechnology
NY
2015
Employment Offer Letter between Amgen Inc. and David W. Meline (CFO Appointment)
Employment Agreements
Amgen Inc.
Biotechnology
2014
Amgen Inc. $4.5 Billion Senior Notes Underwriting Agreement with Multiple Underwriters (2014)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2014
Master Repurchase Agreement between Amgen Inc. and SMBC Repo Pass-Thru Trust, 2013-1 (October 28, 2013)
Repurchase Agreements
Amgen Inc.
Biotechnology
NY
2013
Master Repurchase Agreement between Amgen Inc. and HSBC Bank USA, N.A. dated October 29, 2013
Repurchase Agreements
Amgen Inc.
Biotechnology
NY
2013
Master Repurchase Agreement between Amgen Inc. and Bank of America, N.A. dated August 24, 2013
Repurchase Agreements
Amgen Inc.
Biotechnology
NY
2013
Grant Agreement Between Amgen Inc. and Reed College for Endowed Chair in Chemical Biology
Funding Agreements
Amgen Inc.
Biotechnology
CA
2012
Amgen Inc. Underwriting Agreement for $3 Billion Senior Notes Offering (2017, 2022, 2043)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2012
Amgen Inc. Restricted Stock Unit Award Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2012
Amgen Inc. 2009 Performance Award Program (As Amended March 14, 2012)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2012
Amgen Inc. Performance Unit Award Agreement under 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2012
Amgen Inc. 2009 Director Equity Incentive Program (as Amended March 15, 2012)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2012
Amendment to Consulting Services Agreement between Amgen Inc. and George J. Morrow (2012)
Consulting Agreements
Amgen Inc.
Biotechnology
2012
Consulting Services Agreement between Amgen Inc. and Perlmutter Consulting Inc. (Roger M. Perlmutter)
Consulting Agreements
Amgen Inc.
Biotechnology
CA
2012
Employment Agreement between Amgen Inc. and Anthony C. Hooper (Executive Vice President, Global Commercial Operations)
Employment Agreements
Amgen Inc.
Biotechnology
2012
Amgen Inc. Underwriting Agreement for $6 Billion Senior Notes Offering (2014–2041) with Merrill Lynch and Morgan Stanley
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2011
First Amendment to the Amgen Nonqualified Deferred Compensation Plan (Effective April 11, 2011)
Modification Agreements
Amgen Inc.
Biotechnology
2011
Amgen Inc. Underwriting Agreement for $3 Billion Senior Notes Offering (2016, 2021, 2042) with Barclays, Merrill Lynch, and Morgan Stanley
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2011
Amgen Inc. 2009 Equity Incentive Plan Non-Qualified Stock Option Award Agreement (Form of Award Notice)
Warrant Agreements
Amgen Inc.
Biotechnology
2011
Amgen Inc. 2009 Performance Unit Award Agreement for Employees
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2011
Amgen Inc. 2009 Equity Incentive Plan Non-Qualified Stock Option Award Agreement
Warrant Agreements
Amgen Inc.
Biotechnology
2010
Amgen Inc. Executive Employment Offer Letter to Jonathan Peacock (CFO) Dated July 5, 2010
Employment Agreements
Amgen Inc.
Biotechnology
2010
Amendment No. 1 to Expansion Agreement between Glaxo Group Limited and Amgen Inc.
Modification Agreements
Amgen Inc.
Biotechnology
2010
Consulting Services Agreement between Amgen Inc. and George Morrow (2011)
Consulting Agreements
Amgen Inc.
Biotechnology
CA
2010
Amgen Inc. Underwriting Agreement for $1.5 Billion Senior Notes Offering (2020 & 2041)
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2010
Amgen Inc. 2009 Performance Unit Agreement under Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2010
Amgen Inc. $1 Billion Senior Notes Underwriting Agreement with Banc of America Securities LLC, Barclays Capital Inc., and Morgan Stanley & Co. Incorporated
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2010
Amgen Inc. 2009 Performance Award Program
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2010
Amgen Inc. 2009 Performance Award Program Agreement
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2009
Amgen Inc. 2009 Performance Unit Agreement under Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2009
Amgen Inc. 2009 Performance Award Program
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2009
Amgen Inc. 2009 Performance Unit Agreement under Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2009
Amgen Inc. 2009 Director Equity Incentive Program Agreement
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2009
Amgen Inc. Ex-U.S. Nonqualified Stock Option Grant Agreement for Non-Employee Directors
Warrant Agreements
Amgen Inc.
Biotechnology
DE
2009
Amgen Inc. Underwriting Agreement for $2 Billion Senior Notes (2019 & 2039) with Goldman Sachs, Merrill Lynch, and Morgan Stanley
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2009
Amgen Inc. Amended and Restated 1999 Equity Incentive Plan (Effective December 5, 2005)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
WA
2008
Amgen Inc. Amended and Restated 1999 Incentive Stock Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2008
Amgen Inc. Executive Incentive Plan (as Amended and Restated Effective January 1, 2009)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2008
Amgen Inc. Nonqualified Deferred Compensation Plan (As Amended and Restated Effective January 1, 2009)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2008
Amended and Restated Amgen Inc. Performance Award Program (Effective October 1, 2008)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2008
Variable Term Accelerated Share Repurchase Agreement between Amgen Inc. and Lehman Brothers OTC Derivatives Inc. dated May 28, 2008
Repurchase Agreements
Amgen Inc.
Biotechnology
NY
2008
Amended and Restated Amgen Inc. Performance Award Program (Effective March 21, 2008)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2008
Amgen Inc. Amended and Restated Director Equity Incentive Program (Effective December 10, 2007)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2008
Amendment to Promissory Note between Richard Nanula and Amgen Inc.
Modification Agreements
Amgen Inc.
Biotechnology
2007
Amgen Inc. Director Equity Incentive Program (Amended and Restated Effective March 6, 2007)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2007
Amended and Restated Amgen Inc. Performance Award Program (Effective July 9, 2007)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2007
Amgen Inc. Performance Unit Agreement under the Amended and Restated 1991 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2007
Registration Rights Agreement between Amgen Inc. and Morgan Stanley & Co. Incorporated and Merrill Lynch, Pierce, Fenner & Smith Incorporated, dated May 30, 2007
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2007
Amendment to Amended and Restated Rights Agreement between Amgen Inc. and American Stock Transfer & Trust Company (July 11, 2006)
Modification Agreements
Amgen Inc.
Biotechnology
2006
Confirmation of OTC Warrant Transaction between Amgen Inc. and Merrill Lynch International (February 14, 2006)
Warrant Agreements
Amgen Inc.
Biotechnology
NY
2006
Confirmation of OTC Warrant Transaction between Amgen Inc. and Merrill Lynch International (February 14, 2006)
Warrant Agreements
Amgen Inc.
Biotechnology
NY
2006
Confirmation of OTC Warrant Transaction between Amgen Inc. and Morgan Stanley & Co. International Limited
Warrant Agreements
Amgen Inc.
Biotechnology
NY
2006
Registration Rights Agreement between Amgen Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. Incorporated (February 17, 2006)
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2006
Amgen Inc. Amended and Restated 1997 Equity Incentive Plan (Effective March 7, 2005)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2005
Amended and Restated Amgen Inc. Performance Award Program (Effective December 5, 2005)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan Employee Stock Option Agreement
Warrant Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. Amended and Restated 1997 Equity Incentive Plan Employee Stock Option Agreement
Warrant Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. Amended and Restated 1999 Equity Incentive Plan Employee Stock Option Agreement
Warrant Agreements
Amgen Inc.
Biotechnology
2005
Amended and Restated Performance Unit Agreement between Amgen Inc. and Grantee
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
Amended and Restated Amgen Inc. Director Equity Incentive Program (Effective December 6, 2005)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. Director Equity Incentive Program Amended and Restated Restricted Stock Unit and Nonqualified Stock Option Agreements
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. 4.00% Senior Notes Due 2009 (Form of Note)
Note Agreements
Amgen Inc.
Biotechnology
NY
2005
Amgen Inc. 4.85% Senior Notes Due 2014 (Form of Note)
Note Agreements
Amgen Inc.
Biotechnology
NY
2005
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2005
Amgen Inc. Amended and Restated 1997 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2005
Amended and Restated Amgen Inc. Performance Award Program (Effective March 7, 2005)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. Employee Stock Option Grant Agreement under 1991 Equity Incentive Plan
Warrant Agreements
Amgen Inc.
Biotechnology
DE
2005
Amgen Inc. Employee Stock Option Grant Agreement under 1999 Equity Incentive Plan
Warrant Agreements
Amgen Inc.
Biotechnology
2005
Amgen Inc. Performance Unit Agreement under 1991 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
First Amendment to the Amgen Inc. Executive Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2004
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2004
Amgen Inc. Performance Award Program (Amended and Restated Effective December 6, 2004)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2004
Amgen Inc. Director Equity Incentive Program (Amended and Restated Effective December 6, 2004)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2004
Amgen Inc. 4.00% Senior Notes Due 2009 (Indenture and Note Certificate)
Note Agreements
Amgen Inc.
Biotechnology
NY
2004
Amgen Inc. 4.85% Senior Notes Due 2014 (Indenture Note to Cede & Co., JPMorgan Chase Bank, N.A. as Trustee)
Note Agreements
Amgen Inc.
Biotechnology
NY
2004
Registration Rights Agreement between Amgen Inc. and Morgan Stanley & Co. Incorporated and Merrill Lynch, Pierce, Fenner & Smith Incorporated (November 18, 2004)
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2004
Amendment No. 2 to Enbrel Supply Agreement among Genentech, Immunex, and Amgen
Modification Agreements
Amgen Inc.
Biotechnology
2004
Amendment No. 1 to Amended and Restated Promotion Agreement among Wyeth, Amgen Inc., and Immunex Corporation
Modification Agreements
Amgen Inc.
Biotechnology
2004
Amgen Employment Offer Letter Amendment and Restatement for David Scott
Employment Agreements
Amgen Inc.
Biotechnology
2004
Amgen Inc. Board Resolutions Approving Performance Award Program and Performance Unit Agreement
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2004
Amgen Inc. Performance Unit Agreement under 1991 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2004
Amgen Inc. Amended and Restated 1997 Special Non-Officer Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2003
Amgen Inc. Amended and Restated 1993 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2003
Amgen Inc. Amended and Restated 1999 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
WA
2003
Amended and Restated Employment Agreement between Amgen Inc. and Edward V. Fritzky
Employment Agreements
Amgen Inc.
Biotechnology
WA
2003
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2002
Amgen Inc. Amended and Restated 1997 Special Non-Officer Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2002
Amgen Inc. 2002 Special Severance Pay Plan for Employees
Severance Agreements
Amgen Inc.
Biotechnology
CA
2002
Promissory Note Between Beth C. Seidenberg, Paul S. Vogel, and Amgen Inc. Dated April 2002
Note Agreements
Amgen Inc.
Biotechnology
CA
2002
Employment Agreement between Amgen Inc. and Edward V. Fritzky
Employment Agreements
Amgen Inc.
Biotechnology
WA
2002
Amgen Inc. Stock Option Agreement with Edward V. Fritzky (Exhibit 10.84)
Warrant Agreements
Amgen Inc.
Biotechnology
2002
Amgen Employment Agreement with Dr. Douglas E. Williams (July 15, 2002)
Employment Agreements
Amgen Inc.
Biotechnology
2002
Promissory Note Between Hassan and Katherine Dayem and Amgen Inc. for $500,000 Loan
Note Agreements
Amgen Inc.
Biotechnology
CA
2002
Amgen Inc. Amended and Restated 1997 Special Non-Officer Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2002
Employment Agreement between Amgen Inc. and Dr. Joseph P. Miletich (Senior Vice President, Research & Preclinical Development)
Employment Agreements
Amgen Inc.
Biotechnology
2002
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2002
Amgen Inc. Amended and Restated 1997 Special Non-Officer Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2002
Employment Agreement between Amgen Inc. and Dr. Beth C. Seidenberg (Senior Vice President, Development)
Employment Agreements
Amgen Inc.
Biotechnology
2002
Amendment to Offer Letter Between Amgen Inc. and Dr. Beth C. Seidenberg (December 20, 2001)
Modification Agreements
Amgen Inc.
Biotechnology
2002
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
2001
Amgen Inc. Amended and Restated 1997 Special Non-Officer Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2001
Second Amendment to Amgen Retirement and Savings Plan (Effective October 15, 2001)
Retirement Agreements
Amgen Inc.
Biotechnology
2001
First Amendment to Amgen Supplemental Retirement Plan (Amgen Inc. and Amgen USA Inc.)
Retirement Agreements
Amgen Inc.
Biotechnology
2001
Part-Time Special Assignment Employment Agreement between Amgen Inc. and Dr. George Morstyn (July 19, 2001)
Employment Agreements
Amgen Inc.
Biotechnology
CA
2001
Promissory Note Between Brian M. McNamee, Gillian D. McNamee, and Amgen Inc.
Note Agreements
Amgen Inc.
Biotechnology
CA
2001
Employment Agreement between Amgen Inc. and Brian McNamee (Senior Vice President, Human Resources)
Employment Agreements
Amgen Inc.
Biotechnology
2001
Amgen Inc. Executive Employment Agreement with Richard Nanula (May 14, 2001)
Employment Agreements
Amgen Inc.
Biotechnology
2001
Promissory Note Between Richard Nanula and Amgen Inc. Dated June 27, 2001
Note Agreements
Amgen Inc.
Biotechnology
CA
2001
Promissory Note Between Roger M. Perlmutter, Joan Kreiss, Perlmutter-Kreiss Revocable Living Trust, and Amgen Inc.
Note Agreements
Amgen Inc.
Biotechnology
CA
2001
Amended and Restated Employment Agreement between Amgen Inc. and George J. Morrow (March 2, 2001)
Employment Agreements
Amgen Inc.
Biotechnology
2001
Promissory Note Between George J. Morrow and Amgen Inc. for $1,000,000 Secured by Real Property
Note Agreements
Amgen Inc.
Biotechnology
CA
2001
Amended and Restated Employment Agreement between Amgen Inc. and Dr. Roger M. Perlmutter (March 2, 2001)
Employment Agreements
Amgen Inc.
Biotechnology
2001
Amgen Inc. Amended and Restated 1991 Equity Incentive Plan
Equity Distribution Agreements
Amgen Inc.
Biotechnology
2001
Amgen Inc. Amended and Restated 1997 Special Non-Officer Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2001
Amgen Retirement and Savings Plan (As Amended and Restated Effective October 23, 2000)
Retirement Agreements
Amgen Inc.
Biotechnology
CA
2001
First Amendment to Amgen Retirement and Savings Plan (as Amended and Restated Effective October 23, 2000)
Retirement Agreements
Amgen Inc.
Biotechnology
2001
Kinetix Pharmaceuticals, Inc. Amended and Restated 1997 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2001
Amgen Inc. and Gordon M. Binder Part-Time Special Assignment Employment Agreement (May 2000)
Employment Agreements
Amgen Inc.
Biotechnology
CA
2000